Gapping up
In reaction to strong earnings/guidance:
- CCK +8.4%, AA +4%, AXP +3.8%, ABB +3.7%, BK +3.3%, KMI +2.4%, SNA +2.3%, MDSO +2.2%, BBT +2.1%, DHR +1.6%, WBC +1.2%, KEY +1.2%
Other news:
- XTNT +15.4% (thinly traded; entered into an agreement with Healthcare International Partners for expanding distribution in Latin American markets)
- SIEN +10.5% (announced FDA approval of its PMA supplement allowing commercialization of OPUS-branded breast implant products manufactured by Vesta, a Lubrizol LifeSciences company)
- SHPG +4.7% (Takeda (TKPYY) has made an indicative offer of roughly GBP 46.50/share for Shire, according to Reuters)
- TER +2.7% (still checking - was down 3% on the day along with other semi names - reports earnings next week)
- CENX +2.4% (following AA results)
- AMZN +2.1% (Amazon lifting after releasing letter to shareholders - have exceeded 100 million paid Prime members globally)
- ROKU +2% (Roku rebounding from AMZN / BBY news; confirms plans to release Q1 results May 9 after the close)
- GWPH +1.9% (ahead of today's Peripheral and Central Nervous System Drugs Advisory Committee meeting)
- IBKR +1.2% (rebounding after closing 3.3% lower on the day - SEC has confirmed broker dealer proposals)
- BHP +0.9% (BHP Billiton reports 9-month operations update; reaffirms full year production guidance for petroleum, metallurgical / energy coal; reduces iron ore production guidance), .
Analyst comments:
- EGHT +7.2% (initiated with a Outperform at Oppenheimer)
- NVCR +5.5% (upgraded to Buy from Hold at Deutsche Bank)
- HSBC +1.7% (upgraded to Neutral from Underperform at Credit Suisse)
- S +1.2% (upgraded to Neutral from Underperform at Macquarie)
- TXT +1.1% (upgraded to Buy from Underperform at BofA/Merrill)
![]()